ChemicalBook > Product Catalog >API >Nervous system drugs >Antiepileptic and anticonvulsant >PF-06372865

PF-06372865

PF-06372865 Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com
Company Name: Kaixin Chemical (Hong Kong) Limited  
Tel: 010-88886666-01 13112345678
Email: loyson@qq.com
Company Name: Dideu Industries Group Limited  
Tel: +8617392712697
Email: 1022@dideu.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com

PF-06372865 manufacturers

  • Darigabat
  • Darigabat pictures
  • $49.00
  • 2026-07-15
  • CAS:1614245-70-3
  • Purity: 99.29%
  • Supply Ability: 10g
PF-06372865 Basic information
Product Name:PF-06372865
Synonyms:PF-06372865;7H-Imidazo[4,5-c]pyridazine, 7-ethyl-4-[4'-(ethylsulfonyl)-6-fluoro-2'-methoxy[1,1'-biphenyl]-3-yl]-;PF06372865,PF 06372865;7-Ethyl-4-(4'-(ethylsulfonyl)-6-fluoro-2'-methoxy-[1,1'-biphenyl]-3-yl)-7H-imidazo[4,5-c]pyridazine;CVL-865|||PF-6372865|||PF-06372865;Darigabat, 10 mM in DMSO;CVL-865;Darigabat
CAS:1614245-70-3
MF:C22H21FN4O3S
MW:440.49
EINECS:
Product Categories:
Mol File:1614245-70-3.mol
PF-06372865 Structure
PF-06372865 Chemical Properties
Melting point 184 - 186°C
Boiling point 577.2±60.0 °C(Predicted)
density 1.35±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer, Under inert atmosphere
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
form Solid
pka-0.55±0.30(Predicted)
color White to Light Beige
Safety Information
MSDS Information
PF-06372865 Usage And Synthesis
UsesPF 06372865 are used as GABAA receptor modulators to treat pain.
in vivo

PF-06372865 (compound 34; 3, 10 mg/kg; orally; single dose) significantly increases the paw withdrawal threshold (PWT) in chronic constriction injury (CCI) animals[1].
PF-06372865 (0.3, 3, 10 mg/kg for mouse and 1, 3, 10 mg/kg for rat; orally) exhibits efficacy in two models of epilepsy, PTZ induced seizures (mouse), and amygdala kindling (rat)[1].
PF-06372865 (0.1, 0.32, 1, 3.2 and 10 mg/kg; orally) has anxiolytic activity at 3.2 and 10 mg/kg in elevated plus maze (male C57Bl/6 mice)[1].
PF-06372865 has a T1/2 of 1.1 hours, a Clp of 22 mL/min/kg, and a Vss of 2.1 L/kg for rats[1].
PF-06372865 has a T1/2 of 0.9 hours, a Clp of 29 mL/min/kg, and a Vss of 3.4 L/kg for dogs[1].

Animal Model:Chronic constriction injury (CCI) model (male Wistar rats)[1]
Dosage:3, 10 mg/kg
Administration:Orally
Result:Significantly increased paw withdrawal latency.
PF-06372865 Preparation Products And Raw materials
Tag:PF-06372865(1614245-70-3) Related Product Information
DHEA-S Primidone Phenelzine Sulfate Cefepime 4-Aminobutyric acid Ion Channel Compound Library